APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Genito-Urinary Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Genito-Urinary Drugs Industry Growth and Trends Forecast to 2032

Report ID 173994900120 December 202596 pages

Choose your research edition.

Industry ResearchGenito-Urinary Drugs Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Genito-Urinary Drugs Industry Growth and Trends Forecast to 203296 pages · $3,450 USDMarket StructureGlobal Genito-Urinary Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032185 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Genito-Urinary Drugs Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Genito-Urinary Drugs Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global Genito-Urinary Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Genito-Urinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Genito-Urinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Genito-Urinary Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Genito-Urinary Drugs include Sanofi, Pfizer, GSK, Bayer, AbbVie, Otsuka Pharmaceutical, Daiichi Sankyo Company and Astellas Pharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Genito-Urinary Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Genito-Urinary Drugs market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Genito-Urinary Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Genito-Urinary Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Genito-Urinary Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Genito-Urinary Drugs Market by Company

Sanofi

Pfizer

GSK

Bayer

AbbVie

Otsuka Pharmaceutical

Daiichi Sankyo Company

Astellas Pharma

Genito-Urinary Drugs Segment by Type

OTC

Rx Drugs

Genito-Urinary Drugs Segment by Application

Hospital

Drugs Store

Other

Genito-Urinary Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Genito-Urinary Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Genito-Urinary Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Genito-Urinary Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Genito-Urinary Drugs manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Genito-Urinary Drugs in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of OTC Table 2. Major Company of Rx Drugs Table 3. Global Genito-Urinary Drugs Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Genito-Urinary Drugs Sales by Type (2021-2026) & (K Units) Table 5. Global Genito-Urinary Drugs Sales Market Share in Volume by Type (2021-2026) Table 6. Global Genito-Urinary Drugs Sales by Type (2021-2026) & (US$ Million) Table 7. Global Genito-Urinary Drugs Sales Market Share in Value by Type (2021-2026) Table 8. Global Genito-Urinary Drugs Price by Type (2021-2026) & (US$/Unit) Table 9. Global Genito-Urinary Drugs Sales by Type (2027-2032) & (K Units) Table 10. Global Genito-Urinary Drugs Sales Market Share in Volume by Type (2027-2032) Table 11. Global Genito-Urinary Drugs Sales by Type (2027-2032) & (US$ Million) Table 12. Global Genito-Urinary Drugs Sales Market Share in Value by Type (2027-2032) Table 13. Global Genito-Urinary Drugs Price by Type (2027-2032) & (US$/Unit) Table 14. North America Genito-Urinary Drugs Sales by Type (2021-2026) & (K Units) Table 15. North America Genito-Urinary Drugs Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Genito-Urinary Drugs Sales by Type (2021-2026) & (K Units) Table 17. Europe Genito-Urinary Drugs Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Genito-Urinary Drugs Sales by Type (2021-2026) & (K Units) Table 19. Asia-Pacific Genito-Urinary Drugs Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Genito-Urinary Drugs Sales by Type (2021-2026) & (K Units) Table 21. Latin America Genito-Urinary Drugs Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Genito-Urinary Drugs Sales by Type (2021-2026) & (K Units) Table 23. Middle East and Africa Genito-Urinary Drugs Sales by Type (2021-2026) & (US$ Million) Table 24. Genito-Urinary Drugs Industry Trends Table 25. Genito-Urinary Drugs Industry Drivers Table 26. Genito-Urinary Drugs Industry Opportunities and Challenges Table 27. Genito-Urinary Drugs Industry Restraints Table 28. Global Genito-Urinary Drugs Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Genito-Urinary Drugs Revenue Market Share by Company (2021-2026) Table 30. Global Genito-Urinary Drugs Sales by Company (2021-2026) & (K Units) Table 31. Global Genito-Urinary Drugs Sales Share by Company (2021-2026) Table 32. Global Genito-Urinary Drugs Market Price by Company (2021-2026) & (US$/Unit) Table 33. Global Genito-Urinary Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Genito-Urinary Drugs Major Company Production Sites and Headquarters Table 35. Global Genito-Urinary Drugs Company, Product Type & Application Table 36. Global Genito-Urinary Drugs Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Genito-Urinary Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Genito-Urinary Drugs Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Genito-Urinary Drugs Sales by Region (2021-2026) & (K Units) Table 41. Global Genito-Urinary Drugs Sales Market Share in Volume by Region (2021-2026) Table 42. Global Genito-Urinary Drugs Sales by Region (2021-2026) & (US$ Million) Table 43. Global Genito-Urinary Drugs Sales Market Share in Value by Region (2021-2026) Table 44. Global Genito-Urinary Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 45. Global Genito-Urinary Drugs Sales by Region (2027-2032) & (K Units) Table 46. Global Genito-Urinary Drugs Sales Market Share in Volume by Region (2027-2032) Table 47. Global Genito-Urinary Drugs Sales by Region (2027-2032) & (US$ Million) Table 48. Global Genito-Urinary Drugs Sales Market Share in Value by Region (2027-2032) Table 49. Global Genito-Urinary Drugs Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 50. Global Genito-Urinary Drugs Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Genito-Urinary Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Genito-Urinary Drugs Sales Market Share in Volume by Application (2021-2026) Table 53. Global Genito-Urinary Drugs Sales by Application (2021-2026) & (US$ Million) Table 54. Global Genito-Urinary Drugs Sales Market Share in Value by Application (2021-2026) Table 55. Global Genito-Urinary Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Genito-Urinary Drugs Sales by Application (2027-2032) & (K Units) Table 57. Global Genito-Urinary Drugs Sales Market Share in Volume by Application (2027-2032) Table 58. Global Genito-Urinary Drugs Sales by Application (2027-2032) & (US$ Million) Table 59. Global Genito-Urinary Drugs Sales Market Share in Value by Application (2027-2032) Table 60. Global Genito-Urinary Drugs Price by Application (2027-2032) & (US$/Unit) Table 61. North America Genito-Urinary Drugs Sales by Application (2021-2026) & (K Units) Table 62. North America Genito-Urinary Drugs Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Genito-Urinary Drugs Sales by Application (2021-2026) & (K Units) Table 64. Europe Genito-Urinary Drugs Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Genito-Urinary Drugs Sales by Application (2021-2026) & (K Units) Table 66. Asia-Pacific Genito-Urinary Drugs Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Genito-Urinary Drugs Sales by Application (2021-2026) & (K Units) Table 68. Latin America Genito-Urinary Drugs Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Genito-Urinary Drugs Sales by Application (2021-2026) & (K Units) Table 70. Middle East and Africa Genito-Urinary Drugs Sales by Application (2021-2026) & (US$ Million) Table 71. Sanofi Company Information Table 72. Sanofi Business Overview Table 73. Sanofi Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 74. Sanofi Genito-Urinary Drugs Product Portfolio Table 75. Sanofi Recent Development Table 76. Pfizer Company Information Table 77. Pfizer Business Overview Table 78. Pfizer Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 79. Pfizer Genito-Urinary Drugs Product Portfolio Table 80. Pfizer Recent Development Table 81. GSK Company Information Table 82. GSK Business Overview Table 83. GSK Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 84. GSK Genito-Urinary Drugs Product Portfolio Table 85. GSK Recent Development Table 86. Bayer Company Information Table 87. Bayer Business Overview Table 88. Bayer Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 89. Bayer Genito-Urinary Drugs Product Portfolio Table 90. Bayer Recent Development Table 91. AbbVie Company Information Table 92. AbbVie Business Overview Table 93. AbbVie Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 94. AbbVie Genito-Urinary Drugs Product Portfolio Table 95. AbbVie Recent Development Table 96. Otsuka Pharmaceutical Company Information Table 97. Otsuka Pharmaceutical Business Overview Table 98. Otsuka Pharmaceutical Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 99. Otsuka Pharmaceutical Genito-Urinary Drugs Product Portfolio Table 100. Otsuka Pharmaceutical Recent Development Table 101. Daiichi Sankyo Company Company Information Table 102. Daiichi Sankyo Company Business Overview Table 103. Daiichi Sankyo Company Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 104. Daiichi Sankyo Company Genito-Urinary Drugs Product Portfolio Table 105. Daiichi Sankyo Company Recent Development Table 106. Astellas Pharma Company Information Table 107. Astellas Pharma Business Overview Table 108. Astellas Pharma Genito-Urinary Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 109. Astellas Pharma Genito-Urinary Drugs Product Portfolio Table 110. Astellas Pharma Recent Development Table 111. North America Genito-Urinary Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 112. North America Genito-Urinary Drugs Sales by Country (2021-2026) & (K Units) Table 113. North America Genito-Urinary Drugs Sales Market Share by Country (2021-2026) Table 114. North America Genito-Urinary Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 115. North America Genito-Urinary Drugs Sales Market Share Forecast by Country (2027-2032) Table 116. North America Genito-Urinary Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 117. North America Genito-Urinary Drugs Market Size by Country (2021-2026) & (US$ Million) Table 118. North America Genito-Urinary Drugs Market Share by Country (2021-2026) Table 119. North America Genito-Urinary Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 120. North America Genito-Urinary Drugs Market Share Forecast by Country (2027-2032) Table 121. Europe Genito-Urinary Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 122. Europe Genito-Urinary Drugs Sales by Country (2021-2026) & (K Units) Table 123. Europe Genito-Urinary Drugs Sales Market Share by Country (2021-2026) Table 124. Europe Genito-Urinary Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 125. Europe Genito-Urinary Drugs Sales Market Share Forecast by Country (2027-2032) Table 126. Europe Genito-Urinary Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 127. Europe Genito-Urinary Drugs Market Size by Country (2021-2026) & (US$ Million) Table 128. Europe Genito-Urinary Drugs Market Share by Country (2021-2026) Table 129. Europe Genito-Urinary Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 130. Europe Genito-Urinary Drugs Market Share Forecast by Country (2027-2032) Table 131. Asia-Pacific Genito-Urinary Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 132. Asia-Pacific Genito-Urinary Drugs Sales by Country (2021-2026) & (K Units) Table 133. Asia-Pacific Genito-Urinary Drugs Sales Market Share by Country (2021-2026) Table 134. Asia-Pacific Genito-Urinary Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 135. Asia-Pacific Genito-Urinary Drugs Sales Market Share Forecast by Country (2027-2032) Table 136. Asia-Pacific Genito-Urinary Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 137. Asia-Pacific Genito-Urinary Drugs Market Size by Country (2021-2026) & (US$ Million) Table 138. Asia-Pacific Genito-Urinary Drugs Market Share by Country (2021-2026) Table 139. Asia-Pacific Genito-Urinary Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 140. Asia-Pacific Genito-Urinary Drugs Market Share Forecast by Country (2027-2032) Table 141. Latin America Genito-Urinary Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 142. Latin America Genito-Urinary Drugs Sales by Country (2021-2026) & (K Units) Table 143. Latin America Genito-Urinary Drugs Sales Market Share by Country (2021-2026) Table 144. Latin America Genito-Urinary Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 145. Latin America Genito-Urinary Drugs Sales Market Share Forecast by Country (2027-2032) Table 146. Latin America Genito-Urinary Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 147. Latin America Genito-Urinary Drugs Market Size by Country (2021-2026) & (US$ Million) Table 148. Latin America Genito-Urinary Drugs Market Share by Country (2021-2026) Table 149. Latin America Genito-Urinary Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 150. Latin America Genito-Urinary Drugs Market Share Forecast by Country (2027-2032) Table 151. Middle East and Africa Genito-Urinary Drugs Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 152. Middle East and Africa Genito-Urinary Drugs Sales by Country (2021-2026) & (K Units) Table 153. Middle East and Africa Genito-Urinary Drugs Sales Market Share by Country (2021-2026) Table 154. Middle East and Africa Genito-Urinary Drugs Sales Forecast by Country (2027-2032) & (K Units) Table 155. Middle East and Africa Genito-Urinary Drugs Sales Market Share Forecast by Country (2027-2032) Table 156. Middle East and Africa Genito-Urinary Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 157. Middle East and Africa Genito-Urinary Drugs Market Size by Country (2021-2026) & (US$ Million) Table 158. Middle East and Africa Genito-Urinary Drugs Market Share by Country (2021-2026) Table 159. Middle East and Africa Genito-Urinary Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 160. Middle East and Africa Genito-Urinary Drugs Market Share Forecast by Country (2027-2032) Table 161. Key Raw Materials Table 162. Raw Materials Key Suppliers Table 163. Genito-Urinary Drugs Distributors List Table 164. Genito-Urinary Drugs Customers List Table 165. Research Programs/Design for This Report Table 166. Authors List of This Report Table 167. Secondary Sources Table 168. Primary Sources List of Figures Figure 1. Genito-Urinary Drugs Image Figure 2. Global Genito-Urinary Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Genito-Urinary Drugs Market Size (2021-2032) & (US$ Million) Figure 4. Global Genito-Urinary Drugs Sales (2021-2032) & (K Units) Figure 5. OTC Image Figure 6. Global OTC Sales YoY Growth (2021-2032) & (K Units) Figure 7. Rx Drugs Image Figure 8. Global Rx Drugs Sales YoY Growth (2021-2032) & (K Units) Figure 9. Global Genito-Urinary Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Genito-Urinary Drugs Market Share by Type 2025 VS 2032 Figure 11. North America Genito-Urinary Drugs Sales Market Share in Volume by Type in 2025 Figure 12. North America Genito-Urinary Drugs Sales Market Share in Value by Type in 2025 Figure 13. Europe Genito-Urinary Drugs Sales Market Share in Volume by Type in 2025 Figure 14. Europe Genito-Urinary Drugs Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Genito-Urinary Drugs Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Genito-Urinary Drugs Sales Market Share in Value by Type in 2025 Figure 17. Latin America Genito-Urinary Drugs Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Genito-Urinary Drugs Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Genito-Urinary Drugs Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Genito-Urinary Drugs Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Genito-Urinary Drugs Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hospital Image Figure 24. Global Hospital Sales YoY Growth (2021-2032) & (K Units) Figure 25. Drugs Store Image Figure 26. Global Drugs Store Sales YoY Growth (2021-2032) & (K Units) Figure 27. Other Image Figure 28. Global Other Sales YoY Growth (2021-2032) & (K Units) Figure 29. Global Genito-Urinary Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 30. Global Genito-Urinary Drugs Market Share by Application 2025 VS 2032 Figure 31. North America Genito-Urinary Drugs Sales Market Share in Volume by Application in 2025 Figure 32. North America Genito-Urinary Drugs Sales Market Share in Value by Application in 2025 Figure 33. Europe Genito-Urinary Drugs Sales Market Share in Volume by Application in 2025 Figure 34. Europe Genito-Urinary Drugs Sales Market Share in Value by Application in 2025 Figure 35. Asia-Pacific Genito-Urinary Drugs Sales Market Share in Volume by Application in 2025 Figure 36. Asia-Pacific Genito-Urinary Drugs Sales Market Share in Value by Application in 2025 Figure 37. Latin America Genito-Urinary Drugs Sales Market Share in Volume by Application in 2025 Figure 38. Latin America Genito-Urinary Drugs Sales Market Share in Value by Application in 2025 Figure 39. Middle East and Africa Genito-Urinary Drugs Sales Market Share in Volume by Application in 2025 Figure 40. Middle East and Africa Genito-Urinary Drugs Sales Market Share in Value by Application in 2025 Figure 41. North America Genito-Urinary Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 42. North America Genito-Urinary Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 43. North America Genito-Urinary Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 44. North America Genito-Urinary Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 45. Europe Genito-Urinary Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 46. Europe Genito-Urinary Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Genito-Urinary Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. Europe Genito-Urinary Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Asia-Pacific Genito-Urinary Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 50. Asia-Pacific Genito-Urinary Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Genito-Urinary Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Asia-Pacific Genito-Urinary Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Genito-Urinary Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 54. Latin America Genito-Urinary Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Genito-Urinary Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Latin America Genito-Urinary Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Middle East and Africa Genito-Urinary Drugs Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 58. Middle East and Africa Genito-Urinary Drugs Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Genito-Urinary Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Middle East and Africa Genito-Urinary Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Genito-Urinary Drugs Value Chain Figure 62. Key Raw Materials Price Figure 63. Manufacturing Cost Structure Figure 64. Genito-Urinary Drugs Production Mode & Process Figure 65. Direct Comparison with Distribution Share Figure 66. Distributors Profiles Figure 67. Years Considered Figure 68. Research Process Figure 69. Key Executives Interviewed

Scope & coverage.

Types
  • OTC
  • Rx Drugs
Applications
  • Hospital
  • Drugs Store
  • Other
Companies covered
  • Sanofi
  • Pfizer
  • GSK
  • Bayer
  • AbbVie
  • Otsuka Pharmaceutical
  • Daiichi Sankyo Company
  • Astellas Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Genito-Urinary Drugs Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Genito-Urinary Drugs Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Genito-Urinary Drugs Market by Type
  6. 1.3.1 OTC
  7. 1.3.2 Rx Drugs
  8. 1.4 Global Genito-Urinary Drugs Market Size by Type
  9. 1.4.1 Global Genito-Urinary Drugs Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Genito-Urinary Drugs Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Genito-Urinary Drugs Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Genito-Urinary Drugs Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Genito-Urinary Drugs Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Genito-Urinary Drugs Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Genito-Urinary Drugs Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Genito-Urinary Drugs Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Genito-Urinary Drugs Industry Trends
  2. 2.2 Genito-Urinary Drugs Industry Drivers
  3. 2.3 Genito-Urinary Drugs Industry Opportunities and Challenges
  4. 2.4 Genito-Urinary Drugs Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Genito-Urinary Drugs Revenue (2021-2026)
  2. 3.2 Global Top Players by Genito-Urinary Drugs Sales (2021-2026)
  3. 3.3 Global Top Players by Genito-Urinary Drugs Price (2021-2026)
  4. 3.4 Global Genito-Urinary Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Genito-Urinary Drugs Major Company Production Sites & Headquarters
  6. 3.6 Global Genito-Urinary Drugs Company, Product Type & Application
  7. 3.7 Global Genito-Urinary Drugs Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Genito-Urinary Drugs Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Genito-Urinary Drugs Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Genito-Urinary Drugs Tier 1, Tier 2, and Tier 3
4 Genito-Urinary Drugs Regional Status and Outlook
  1. 4.1 Global Genito-Urinary Drugs Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Genito-Urinary Drugs Historic Market Size by Region
  3. 4.2.1 Global Genito-Urinary Drugs Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Genito-Urinary Drugs Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Genito-Urinary Drugs Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Genito-Urinary Drugs Forecasted Market Size by Region
  7. 4.3.1 Global Genito-Urinary Drugs Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Genito-Urinary Drugs Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Genito-Urinary Drugs Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Genito-Urinary Drugs by Application
  1. 5.1 Genito-Urinary Drugs Market by Application
  2. 5.1.1 Hospital
  3. 5.1.2 Drugs Store
  4. 5.1.3 Other
  5. 5.2 Global Genito-Urinary Drugs Market Size by Application
  6. 5.2.1 Global Genito-Urinary Drugs Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Genito-Urinary Drugs Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Genito-Urinary Drugs Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Genito-Urinary Drugs Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Genito-Urinary Drugs Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Genito-Urinary Drugs Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Genito-Urinary Drugs Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Genito-Urinary Drugs Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi
  2. 6.1.1 Sanofi Company Information
  3. 6.1.2 Sanofi Business Overview
  4. 6.1.3 Sanofi Genito-Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi Genito-Urinary Drugs Product Portfolio
  6. 6.1.5 Sanofi Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer Genito-Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Pfizer Genito-Urinary Drugs Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK Genito-Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 GSK Genito-Urinary Drugs Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer Genito-Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Bayer Genito-Urinary Drugs Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 AbbVie
  26. 6.5.1 AbbVie Company Information
  27. 6.5.2 AbbVie Business Overview
  28. 6.5.3 AbbVie Genito-Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 AbbVie Genito-Urinary Drugs Product Portfolio
  30. 6.5.5 AbbVie Recent Developments
  31. 6.6 Otsuka Pharmaceutical
  32. 6.6.1 Otsuka Pharmaceutical Company Information
  33. 6.6.2 Otsuka Pharmaceutical Business Overview
  34. 6.6.3 Otsuka Pharmaceutical Genito-Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Otsuka Pharmaceutical Genito-Urinary Drugs Product Portfolio
  36. 6.6.5 Otsuka Pharmaceutical Recent Developments
  37. 6.7 Daiichi Sankyo Company
  38. 6.7.1 Daiichi Sankyo Company Company Information
  39. 6.7.2 Daiichi Sankyo Company Business Overview
  40. 6.7.3 Daiichi Sankyo Company Genito-Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Daiichi Sankyo Company Genito-Urinary Drugs Product Portfolio
  42. 6.7.5 Daiichi Sankyo Company Recent Developments
  43. 6.8 Astellas Pharma
  44. 6.8.1 Astellas Pharma Company Information
  45. 6.8.2 Astellas Pharma Business Overview
  46. 6.8.3 Astellas Pharma Genito-Urinary Drugs Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Astellas Pharma Genito-Urinary Drugs Product Portfolio
  48. 6.8.5 Astellas Pharma Recent Developments
7 North America by Country
  1. 7.1 North America Genito-Urinary Drugs Sales by Country
  2. 7.1.1 North America Genito-Urinary Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Genito-Urinary Drugs Sales by Country (2021-2026)
  4. 7.1.3 North America Genito-Urinary Drugs Sales Forecast by Country (2027-2032)
  5. 7.2 North America Genito-Urinary Drugs Market Size by Country
  6. 7.2.1 North America Genito-Urinary Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Genito-Urinary Drugs Market Size by Country (2021-2026)
  8. 7.2.3 North America Genito-Urinary Drugs Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Genito-Urinary Drugs Sales by Country
  2. 8.1.1 Europe Genito-Urinary Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Genito-Urinary Drugs Sales by Country (2021-2026)
  4. 8.1.3 Europe Genito-Urinary Drugs Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Genito-Urinary Drugs Market Size by Country
  6. 8.2.1 Europe Genito-Urinary Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Genito-Urinary Drugs Market Size by Country (2021-2026)
  8. 8.2.3 Europe Genito-Urinary Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Genito-Urinary Drugs Sales by Country
  2. 9.1.1 Asia-Pacific Genito-Urinary Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Genito-Urinary Drugs Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Genito-Urinary Drugs Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Genito-Urinary Drugs Market Size by Country
  6. 9.2.1 Asia-Pacific Genito-Urinary Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Genito-Urinary Drugs Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Genito-Urinary Drugs Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Genito-Urinary Drugs Sales by Country
  2. 10.1.1 South America Genito-Urinary Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Genito-Urinary Drugs Sales by Country (2021-2026)
  4. 10.1.3 South America Genito-Urinary Drugs Sales Forecast by Country (2027-2032)
  5. 10.2 South America Genito-Urinary Drugs Market Size by Country
  6. 10.2.1 South America Genito-Urinary Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Genito-Urinary Drugs Market Size by Country (2021-2026)
  8. 10.2.3 South America Genito-Urinary Drugs Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Genito-Urinary Drugs Sales by Country
  2. 11.1.1 Middle East and Africa Genito-Urinary Drugs Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Genito-Urinary Drugs Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Genito-Urinary Drugs Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Genito-Urinary Drugs Market Size by Country
  6. 11.2.1 Middle East and Africa Genito-Urinary Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Genito-Urinary Drugs Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Genito-Urinary Drugs Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Genito-Urinary Drugs Value Chain Analysis
  2. 12.1.1 Genito-Urinary Drugs Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Genito-Urinary Drugs Production Mode & Process
  7. 12.2 Genito-Urinary Drugs Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Genito-Urinary Drugs Distributors
  10. 12.2.3 Genito-Urinary Drugs Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst